Exposure response relationship studies in IBD patients clearly demonstrate that higher anti-TNF drug concentrations are associated with clinical, biochemical, endoscopic, and histological remission (Zittan et al., 2016; Ward et al., 2017; Papamichael et al., 2018). Here, TNF is linked to inflammatory bowel disease.